Global Pharmacokinetics Testing Service Market Research Report 2026

Pharmacokinetics Testing Service Market

Pharmacokinetics Testing Service is a specialized technical service in the pharmaceutical R&D ecosystem that systematically studies the dynamic processes of drugs (including small-molecule chemicals, biologics, and traditional Chinese medicine ingredients) within living organisms, focusing on their Absorption, Distribution, Metabolism, and Excretion (ADME) as well as the quantitative changes in drug concentrations over time. The core purpose of this service is to evaluate how the body processes a drug, support rational drug formulation design, optimize dosage regimens, assess drug-drug interaction risks, verify bioequivalence for generic drugs, and provide critical data to meet regulatory requirements (e.g., FDA, NMPA, EMA) for new drug applications (NDA) and marketing authorization. Typically offered by contract research organizations (CROs), pharmaceutical companies’ in-house R&D departments, or academic research institutions, pharmacokinetics testing services play a pivotal role in ensuring drug safety, efficacy, and clinical translatability throughout the drug development lifecycle.

The pharmacokinetics testing service market is expected to witness significant growth in the coming years. This can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and advancements in drug development and clinical trials.North America is expected to dominate the pharmacokinetics testing service market due to the presence of a well-established healthcare infrastructure, increasing R&D activities, and a large number of pharmaceutical companies in the region.Europe is also a significant market for pharmacokinetics testing services, driven by the presence of major pharmaceutical companies, increasing investments in drug development, and favorable government initiatives.The Asia Pacific region is expected to witness rapid growth in the pharmacokinetics testing service market due to the increasing outsourcing of drug development activities to countries like India and China, rising healthcare expenditure, and a large patient pool.The pharmacokinetics testing service market is highly fragmented, with the presence of numerous small and large players. However, a few major players dominate the market, accounting for a significant market share. These players have a strong presence in multiple regions and offer a wide range of pharmacokinetics testing services.The increasing focus on personalized medicine and targeted therapies presents significant opportunities for pharmacokinetics testing service providers. Personalized medicine requires precise pharmacokinetic data to determine the optimal drug dosage for individual patients.Technological advancements, such as the development of advanced analytical techniques and high-throughput screening methods, are expected to create new opportunities in the pharmacokinetics testing service market. These advancements enable faster and more accurate analysis of drug metabolism and pharmacokinetic parameters.The pharmacokinetics testing service market is subject to strict regulatory requirements, which can pose challenges for service providers. Compliance with regulatory guidelines and obtaining necessary approvals can be time-consuming and costly. Pharmacokinetics testing services can be expensive, especially for small and medium-sized pharmaceutical companies. The high cost of testing services can act as a barrier to market entry for some players and limit the adoption of these services.Overall, the pharmacokinetics testing service market is expected to grow significantly in the coming years, driven by factors such as the increasing demand for personalized medicine and advancements in drug development. However, challenges such as stringent regulatory requirements and high testing costs need to be addressed for the market to reach its full potential.

This report delivers a comprehensive overview of the global Pharmacokinetics Testing Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmacokinetics Testing Service. The Pharmacokinetics Testing Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pharmacokinetics Testing Service market comprehensively. Regional market sizes by Type, by Application, by Tested Drug Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pharmacokinetics Testing Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pharmacokinetics Testing Service Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacokinetics Testing Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Preclinical Pharmacokinetics Testing

1.2.3 Clinical Pharmacokinetics Testing

1.3 Market by Tested Drug Type

1.3.1 Global Pharmacokinetics Testing Service Market Size Growth Rate by Tested Drug Type: 2021 vs 2025 vs 2032

1.3.2 Small-Molecule Drug Pharmacokinetics Testing

1.3.3 Biologics Pharmacokinetics Testing

1.3.4 Other

1.4 Market by Analytical Technology Platform

1.4.1 Global Pharmacokinetics Testing Service Market Size Growth Rate by Analytical Technology Platform: 2021 vs 2025 vs 2032

1.4.2 LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) Testing

1.4.3 HPLC (High-Performance Liquid Chromatography) Testing

1.4.4 Others

1.5 Market by Application

1.5.1 Global Pharmacokinetics Testing Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Drug Development

1.5.3 Clinical Trials

1.5.4 Veterinary Medicine

1.5.5 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2.1 Global Pharmacokinetics Testing Service Market Perspective (2021–2032)

2.2 Global Pharmacokinetics Testing Service Growth Trends by Region

2.2.1 Global Pharmacokinetics Testing Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Pharmacokinetics Testing Service Historic Market Size by Region (2021–2026)

2.2.3 Pharmacokinetics Testing Service Forecasted Market Size by Region (2027–2032)

2.3 Pharmacokinetics Testing Service Market Dynamics

2.3.1 Pharmacokinetics Testing Service Industry Trends

2.3.2 Pharmacokinetics Testing Service Market Drivers

2.3.3 Pharmacokinetics Testing Service Market Challenges

2.3.4 Pharmacokinetics Testing Service Market Restraints

3.1 Global Top Pharmacokinetics Testing Service Players by Revenue

3.1.1 Global Top Pharmacokinetics Testing Service Players by Revenue (2021–2026)

3.1.2 Global Pharmacokinetics Testing Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Pharmacokinetics Testing Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Pharmacokinetics Testing Service Revenue

3.4 Global Pharmacokinetics Testing Service Market Concentration Ratio

3.4.1 Global Pharmacokinetics Testing Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Testing Service Revenue in 2025

3.5 Global Key Players of Pharmacokinetics Testing Service Head Offices and Areas Served

3.6 Global Key Players of Pharmacokinetics Testing Service, Products and Applications

3.7 Global Key Players of Pharmacokinetics Testing Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4.1 Global Pharmacokinetics Testing Service Historic Market Size by Type (2021–2026)

4.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Type (2027–2032)

5.1 Global Pharmacokinetics Testing Service Historic Market Size by Application (2021–2026)

5.2 Global Pharmacokinetics Testing Service Forecasted Market Size by Application (2027–2032)

6.1 North America Pharmacokinetics Testing Service Market Size (2021–2032)

6.2 North America Pharmacokinetics Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Pharmacokinetics Testing Service Market Size by Country (2021–2026)

6.4 North America Pharmacokinetics Testing Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7.1 Europe Pharmacokinetics Testing Service Market Size (2021–2032)

7.2 Europe Pharmacokinetics Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Pharmacokinetics Testing Service Market Size by Country (2021–2026)

7.4 Europe Pharmacokinetics Testing Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific Pharmacokinetics Testing Service Market Size (2021–2032)

8.2 Asia-Pacific Pharmacokinetics Testing Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America Pharmacokinetics Testing Service Market Size (2021–2032)

9.2 Latin America Pharmacokinetics Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Pharmacokinetics Testing Service Market Size by Country (2021–2026)

9.4 Latin America Pharmacokinetics Testing Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pharmacokinetics Testing Service Market Size (2021–2032)

10.2 Middle East & Africa Pharmacokinetics Testing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 Proteomics International

11.1.1 Proteomics International Company Details

11.1.2 Proteomics International Business Overview

11.1.3 Proteomics International Pharmacokinetics Testing Service Introduction

11.1.4 Proteomics International Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.1.5 Proteomics International Recent Development

11.2 Labcorp

11.2.1 Labcorp Company Details

11.2.2 Labcorp Business Overview

11.2.3 Labcorp Pharmacokinetics Testing Service Introduction

11.2.4 Labcorp Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.2.5 Labcorp Recent Development

11.3 Pharmaron

11.3.1 Pharmaron Company Details

11.3.2 Pharmaron Business Overview

11.3.3 Pharmaron Pharmacokinetics Testing Service Introduction

11.3.4 Pharmaron Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.3.5 Pharmaron Recent Development

11.4 Svar

11.4.1 Svar Company Details

11.4.2 Svar Business Overview

11.4.3 Svar Pharmacokinetics Testing Service Introduction

11.4.4 Svar Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.4.5 Svar Recent Development

11.5 NorthEast BioLab

11.5.1 NorthEast BioLab Company Details

11.5.2 NorthEast BioLab Business Overview

11.5.3 NorthEast BioLab Pharmacokinetics Testing Service Introduction

11.5.4 NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.5.5 NorthEast BioLab Recent Development

11.6 BioAgilytix

11.6.1 BioAgilytix Company Details

11.6.2 BioAgilytix Business Overview

11.6.3 BioAgilytix Pharmacokinetics Testing Service Introduction

11.6.4 BioAgilytix Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.6.5 BioAgilytix Recent Development

11.7 Mediford Corporation

11.7.1 Mediford Corporation Company Details

11.7.2 Mediford Corporation Business Overview

11.7.3 Mediford Corporation Pharmacokinetics Testing Service Introduction

11.7.4 Mediford Corporation Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.7.5 Mediford Corporation Recent Development

11.8 Eurofins BioPharma

11.8.1 Eurofins BioPharma Company Details

11.8.2 Eurofins BioPharma Business Overview

11.8.3 Eurofins BioPharma Pharmacokinetics Testing Service Introduction

11.8.4 Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.8.5 Eurofins BioPharma Recent Development

11.9 Charles River Laboratories

11.9.1 Charles River Laboratories Company Details

11.9.2 Charles River Laboratories Business Overview

11.9.3 Charles River Laboratories Pharmacokinetics Testing Service Introduction

11.9.4 Charles River Laboratories Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.9.5 Charles River Laboratories Recent Development

11.10 SCAS

11.10.1 SCAS Company Details

11.10.2 SCAS Business Overview

11.10.3 SCAS Pharmacokinetics Testing Service Introduction

11.10.4 SCAS Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.10.5 SCAS Recent Development

11.11 Chimera

11.11.1 Chimera Company Details

11.11.2 Chimera Business Overview

11.11.3 Chimera Pharmacokinetics Testing Service Introduction

11.11.4 Chimera Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.11.5 Chimera Recent Development

11.12 Phoenix WinNonlin

11.12.1 Phoenix WinNonlin Company Details

11.12.2 Phoenix WinNonlin Business Overview

11.12.3 Phoenix WinNonlin Pharmacokinetics Testing Service Introduction

11.12.4 Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.12.5 Phoenix WinNonlin Recent Development

11.13 CD bioparticles

11.13.1 CD bioparticles Company Details

11.13.2 CD bioparticles Business Overview

11.13.3 CD bioparticles Pharmacokinetics Testing Service Introduction

11.13.4 CD bioparticles Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.13.5 CD bioparticles Recent Development

11.14 ACM Global Laboratories

11.14.1 ACM Global Laboratories Company Details

11.14.2 ACM Global Laboratories Business Overview

11.14.3 ACM Global Laboratories Pharmacokinetics Testing Service Introduction

11.14.4 ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.14.5 ACM Global Laboratories Recent Development

11.15 WuXi AppTec

11.15.1 WuXi AppTec Company Details

11.15.2 WuXi AppTec Business Overview

11.15.3 WuXi AppTec Pharmacokinetics Testing Service Introduction

11.15.4 WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.15.5 WuXi AppTec Recent Development

11.16 BioGenes

11.16.1 BioGenes Company Details

11.16.2 BioGenes Business Overview

11.16.3 BioGenes Pharmacokinetics Testing Service Introduction

11.16.4 BioGenes Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.16.5 BioGenes Recent Development

11.17 Pacific BioLabs

11.17.1 Pacific BioLabs Company Details

11.17.2 Pacific BioLabs Business Overview

11.17.3 Pacific BioLabs Pharmacokinetics Testing Service Introduction

11.17.4 Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.17.5 Pacific BioLabs Recent Development

11.18 XenoTech

11.18.1 XenoTech Company Details

11.18.2 XenoTech Business Overview

11.18.3 XenoTech Pharmacokinetics Testing Service Introduction

11.18.4 XenoTech Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.18.5 XenoTech Recent Development

11.19 Medpace

11.19.1 Medpace Company Details

11.19.2 Medpace Business Overview

11.19.3 Medpace Pharmacokinetics Testing Service Introduction

11.19.4 Medpace Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.19.5 Medpace Recent Development

11.20 SGS

11.20.1 SGS Company Details

11.20.2 SGS Business Overview

11.20.3 SGS Pharmacokinetics Testing Service Introduction

11.20.4 SGS Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.20.5 SGS Recent Development

11.21 CellCarta

11.21.1 CellCarta Company Details

11.21.2 CellCarta Business Overview

11.21.3 CellCarta Pharmacokinetics Testing Service Introduction

11.21.4 CellCarta Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.21.5 CellCarta Recent Development

11.22 Precision

11.22.1 Precision Company Details

11.22.2 Precision Business Overview

11.22.3 Precision Pharmacokinetics Testing Service Introduction

11.22.4 Precision Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.22.5 Precision Recent Development

11.23 360biolabs

11.23.1 360biolabs Company Details

11.23.2 360biolabs Business Overview

11.23.3 360biolabs Pharmacokinetics Testing Service Introduction

11.23.4 360biolabs Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.23.5 360biolabs Recent Development

11.24 Porsolt

11.24.1 Porsolt Company Details

11.24.2 Porsolt Business Overview

11.24.3 Porsolt Pharmacokinetics Testing Service Introduction

11.24.4 Porsolt Revenue in Pharmacokinetics Testing Service Business (2021–2026)

11.24.5 Porsolt Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Pharmacokinetics Testing Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

 Table 2. Key Players of Preclinical Pharmacokinetics Testing

 Table 3. Key Players of Clinical Pharmacokinetics Testing

 Table 4. Global Pharmacokinetics Testing Service Market Size Growth Rate by Tested Drug Type (US$ Million): 2021 vs 2025 vs 2032

 Table 5. Key Players of Small-Molecule Drug Pharmacokinetics Testing

 Table 6. Key Players of Biologics Pharmacokinetics Testing

 Table 7. Key Players of Other

 Table 8. Global Pharmacokinetics Testing Service Market Size Growth Rate by Analytical Technology Platform (US$ Million): 2021 vs 2025 vs 2032

 Table 9. Key Players of LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) Testing

 Table 10. Key Players of HPLC (High-Performance Liquid Chromatography) Testing

 Table 11. Key Players of Others

 Table 12. Global Pharmacokinetics Testing Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

 Table 13. Global Pharmacokinetics Testing Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 14. Global Pharmacokinetics Testing Service Market Size by Region (US$ Million), 2021–2026

 Table 15. Global Pharmacokinetics Testing Service Market Share by Region (2021–2026)

 Table 16. Global Pharmacokinetics Testing Service Forecasted Market Size by Region (US$ Million), 2027–2032

 Table 17. Global Pharmacokinetics Testing Service Market Share by Region (2027–2032)

 Table 18. Pharmacokinetics Testing Service Market Trends

 Table 19. Pharmacokinetics Testing Service Market Drivers

 Table 20. Pharmacokinetics Testing Service Market Challenges

 Table 21. Pharmacokinetics Testing Service Market Restraints

 Table 22. Global Pharmacokinetics Testing Service Revenue by Players (US$ Million), 2021–2026

 Table 23. Global Pharmacokinetics Testing Service Market Share by Players (2021–2026)

 Table 24. Global Top Pharmacokinetics Testing Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmacokinetics Testing Service Revenue, 2025

 Table 25. Ranking of Global Top Pharmacokinetics Testing Service Companies by Revenue (US$ Million) in 2025

 Table 26. Global 5 Largest Players Market Share by Pharmacokinetics Testing Service Revenue (CR5 and HHI), 2021–2026

 Table 27. Global Key Players of Pharmacokinetics Testing Service, Headquarters and Area Served

 Table 28. Global Key Players of Pharmacokinetics Testing Service, Products and Applications

 Table 29. Global Key Players of Pharmacokinetics Testing Service, Date of General Availability (GA)

 Table 30. Mergers and Acquisitions, Expansion Plans

 Table 31. Global Pharmacokinetics Testing Service Market Size by Type (US$ Million), 2021–2026

 Table 32. Global Pharmacokinetics Testing Service Revenue Market Share by Type (2021–2026)

 Table 33. Global Pharmacokinetics Testing Service Forecasted Market Size by Type (US$ Million), 2027–2032

 Table 34. Global Pharmacokinetics Testing Service Revenue Market Share by Type (2027–2032)

 Table 35. Global Pharmacokinetics Testing Service Market Size by Application (US$ Million), 2021–2026

 Table 36. Global Pharmacokinetics Testing Service Revenue Market Share by Application (2021–2026)

 Table 37. Global Pharmacokinetics Testing Service Forecasted Market Size by Application (US$ Million), 2027–2032

 Table 38. Global Pharmacokinetics Testing Service Revenue Market Share by Application (2027–2032)

 Table 39. North America Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 40. North America Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2021–2026

 Table 41. North America Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2027–2032

 Table 42. Europe Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 43. Europe Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2021–2026

 Table 44. Europe Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2027–2032

 Table 45. Asia-Pacific Pharmacokinetics Testing Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 46. Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (US$ Million), 2021–2026

 Table 47. Asia-Pacific Pharmacokinetics Testing Service Market Size by Region (US$ Million), 2027–2032

 Table 48. Latin America Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 49. Latin America Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2021–2026

 Table 50. Latin America Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2027–2032

 Table 51. Middle East & Africa Pharmacokinetics Testing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 52. Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2021–2026

 Table 53. Middle East & Africa Pharmacokinetics Testing Service Market Size by Country (US$ Million), 2027–2032

 Table 54. Proteomics International Company Details

 Table 55. Proteomics International Business Overview

 Table 56. Proteomics International Pharmacokinetics Testing Service Product

 Table 57. Proteomics International Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 58. Proteomics International Recent Development

 Table 59. Labcorp Company Details

 Table 60. Labcorp Business Overview

 Table 61. Labcorp Pharmacokinetics Testing Service Product

 Table 62. Labcorp Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 63. Labcorp Recent Development

 Table 64. Pharmaron Company Details

 Table 65. Pharmaron Business Overview

 Table 66. Pharmaron Pharmacokinetics Testing Service Product

 Table 67. Pharmaron Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 68. Pharmaron Recent Development

 Table 69. Svar Company Details

 Table 70. Svar Business Overview

 Table 71. Svar Pharmacokinetics Testing Service Product

 Table 72. Svar Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 73. Svar Recent Development

 Table 74. NorthEast BioLab Company Details

 Table 75. NorthEast BioLab Business Overview

 Table 76. NorthEast BioLab Pharmacokinetics Testing Service Product

 Table 77. NorthEast BioLab Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 78. NorthEast BioLab Recent Development

 Table 79. BioAgilytix Company Details

 Table 80. BioAgilytix Business Overview

 Table 81. BioAgilytix Pharmacokinetics Testing Service Product

 Table 82. BioAgilytix Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 83. BioAgilytix Recent Development

 Table 84. Mediford Corporation Company Details

 Table 85. Mediford Corporation Business Overview

 Table 86. Mediford Corporation Pharmacokinetics Testing Service Product

 Table 87. Mediford Corporation Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 88. Mediford Corporation Recent Development

 Table 89. Eurofins BioPharma Company Details

 Table 90. Eurofins BioPharma Business Overview

 Table 91. Eurofins BioPharma Pharmacokinetics Testing Service Product

 Table 92. Eurofins BioPharma Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 93. Eurofins BioPharma Recent Development

 Table 94. Charles River Laboratories Company Details

 Table 95. Charles River Laboratories Business Overview

 Table 96. Charles River Laboratories Pharmacokinetics Testing Service Product

 Table 97. Charles River Laboratories Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 98. Charles River Laboratories Recent Development

 Table 99. SCAS Company Details

 Table 100. SCAS Business Overview

 Table 101. SCAS Pharmacokinetics Testing Service Product

 Table 102. SCAS Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 103. SCAS Recent Development

 Table 104. Chimera Company Details

 Table 105. Chimera Business Overview

 Table 106. Chimera Pharmacokinetics Testing Service Product

 Table 107. Chimera Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 108. Chimera Recent Development

 Table 109. Phoenix WinNonlin Company Details

 Table 110. Phoenix WinNonlin Business Overview

 Table 111. Phoenix WinNonlin Pharmacokinetics Testing Service Product

 Table 112. Phoenix WinNonlin Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 113. Phoenix WinNonlin Recent Development

 Table 114. CD bioparticles Company Details

 Table 115. CD bioparticles Business Overview

 Table 116. CD bioparticles Pharmacokinetics Testing Service Product

 Table 117. CD bioparticles Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 118. CD bioparticles Recent Development

 Table 119. ACM Global Laboratories Company Details

 Table 120. ACM Global Laboratories Business Overview

 Table 121. ACM Global Laboratories Pharmacokinetics Testing Service Product

 Table 122. ACM Global Laboratories Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 123. ACM Global Laboratories Recent Development

 Table 124. WuXi AppTec Company Details

 Table 125. WuXi AppTec Business Overview

 Table 126. WuXi AppTec Pharmacokinetics Testing Service Product

 Table 127. WuXi AppTec Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 128. WuXi AppTec Recent Development

 Table 129. BioGenes Company Details

 Table 130. BioGenes Business Overview

 Table 131. BioGenes Pharmacokinetics Testing Service Product

 Table 132. BioGenes Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 133. BioGenes Recent Development

 Table 134. Pacific BioLabs Company Details

 Table 135. Pacific BioLabs Business Overview

 Table 136. Pacific BioLabs Pharmacokinetics Testing Service Product

 Table 137. Pacific BioLabs Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 138. Pacific BioLabs Recent Development

 Table 139. XenoTech Company Details

 Table 140. XenoTech Business Overview

 Table 141. XenoTech Pharmacokinetics Testing Service Product

 Table 142. XenoTech Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 143. XenoTech Recent Development

 Table 144. Medpace Company Details

 Table 145. Medpace Business Overview

 Table 146. Medpace Pharmacokinetics Testing Service Product

 Table 147. Medpace Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 148. Medpace Recent Development

 Table 149. SGS Company Details

 Table 150. SGS Business Overview

 Table 151. SGS Pharmacokinetics Testing Service Product

 Table 152. SGS Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 153. SGS Recent Development

 Table 154. CellCarta Company Details

 Table 155. CellCarta Business Overview

 Table 156. CellCarta Pharmacokinetics Testing Service Product

 Table 157. CellCarta Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 158. CellCarta Recent Development

 Table 159. Precision Company Details

 Table 160. Precision Business Overview

 Table 161. Precision Pharmacokinetics Testing Service Product

 Table 162. Precision Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 163. Precision Recent Development

 Table 164. 360biolabs Company Details

 Table 165. 360biolabs Business Overview

 Table 166. 360biolabs Pharmacokinetics Testing Service Product

 Table 167. 360biolabs Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 168. 360biolabs Recent Development

 Table 169. Porsolt Company Details

 Table 170. Porsolt Business Overview

 Table 171. Porsolt Pharmacokinetics Testing Service Product

 Table 172. Porsolt Revenue in Pharmacokinetics Testing Service Business (US$ Million), 2021–2026

 Table 173. Porsolt Recent Development

 Table 174. Research Programs/Design for This Report

 Table 175. Key Data Information from Secondary Sources

 Table 176. Key Data Information from Primary Sources

 Table 177. Authors List of This Report

List of Figures

 Figure 1. Pharmacokinetics Testing Service Picture

 Figure 2. Global Pharmacokinetics Testing Service Market Size Comparison by Type (US$ Million), 2021–2032

 Figure 3. Global Pharmacokinetics Testing Service Market Share by Type: 2025 vs 2032

 Figure 4. Preclinical Pharmacokinetics Testing Features

 Figure 5. Clinical Pharmacokinetics Testing Features

 Figure 6. Global Pharmacokinetics Testing Service Market Size Comparison by Tested Drug Type (US$ Million), 2021–2032

 Figure 7. Small-Molecule Drug Pharmacokinetics Testing Features

 Figure 8. Biologics Pharmacokinetics Testing Features

 Figure 9. Other Features

 Figure 10. Global Pharmacokinetics Testing Service Market Size Comparison by Analytical Technology Platform (US$ Million), 2021–2032

 Figure 11. LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) Testing Features

 Figure 12. HPLC (High-Performance Liquid Chromatography) Testing Features

 Figure 13. Others Features

 Figure 14. Global Pharmacokinetics Testing Service Market Size by Application (US$ Million), 2021–2032

 Figure 15. Global Pharmacokinetics Testing Service Market Share by Application: 2025 vs 2032

 Figure 16. Drug Development Case Studies

 Figure 17. Clinical Trials Case Studies

 Figure 18. Veterinary Medicine Case Studies

 Figure 19. Other Case Studies

 Figure 20. Pharmacokinetics Testing Service Report Years Considered

 Figure 21. Global Pharmacokinetics Testing Service Market Size (US$ Million), Year-over-Year: 2021–2032

 Figure 22. Global Pharmacokinetics Testing Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

 Figure 23. Global Pharmacokinetics Testing Service Market Share by Region: 2025 vs 2032

 Figure 24. Global Pharmacokinetics Testing Service Market Share by Players in 2025

 Figure 25. Global Pharmacokinetics Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 26. The Top 10 and 5 Players Market Share by Pharmacokinetics Testing Service Revenue in 2025

 Figure 27. North America Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 28. North America Pharmacokinetics Testing Service Market Share by Country (2021–2032)

 Figure 29. United States Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 30. Canada Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 31. Europe Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 32. Europe Pharmacokinetics Testing Service Market Share by Country (2021–2032)

 Figure 33. Germany Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 34. France Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 35. U.K. Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 36. Italy Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 37. Russia Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 38. Ireland Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 39. Asia-Pacific Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 40. Asia-Pacific Pharmacokinetics Testing Service Market Share by Region (2021–2032)

 Figure 41. China Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 42. Japan Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 43. South Korea Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 44. Southeast Asia Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 45. India Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 46. Australia & New Zealand Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 47. Latin America Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 48. Latin America Pharmacokinetics Testing Service Market Share by Country (2021–2032)

 Figure 49. Mexico Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 50. Brazil Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 51. Middle East & Africa Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 52. Middle East & Africa Pharmacokinetics Testing Service Market Share by Country (2021–2032)

 Figure 53. Israel Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 54. Saudi Arabia Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 55. UAE Pharmacokinetics Testing Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 56. Proteomics International Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 57. Labcorp Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 58. Pharmaron Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 59. Svar Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 60. NorthEast BioLab Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 61. BioAgilytix Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 62. Mediford Corporation Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 63. Eurofins BioPharma Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 64. Charles River Laboratories Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 65. SCAS Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 66. Chimera Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 67. Phoenix WinNonlin Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 68. CD bioparticles Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 69. ACM Global Laboratories Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 70. WuXi AppTec Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 71. BioGenes Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 72. Pacific BioLabs Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 73. XenoTech Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 74. Medpace Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 75. SGS Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 76. CellCarta Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 77. Precision Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 78. 360biolabs Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 79. Porsolt Revenue Growth Rate in Pharmacokinetics Testing Service Business (2021–2026)

 Figure 80. Bottom-up and Top-down Approaches for This Report

 Figure 81. Data Triangulation

 Figure 82. Key Executives Interviewed